ASH 2022: New clinical data challenge long-held assumptionsDecember 7, 2022Mixed TopicsTransplantHodgkin LymphomaALLPatient & Survivor CareMantle Cell LymphomaAML
CAR T-cell therapy neurotoxicity linked to NfL elevationsOctober 3, 2022Cellular TherapyAggressive LymphomasALLB Cell LymphomaMultiple MyelomaMixed TopicsCLL
First drug therapy approved for childhood GVHDAugust 26, 2022ALLAMLMixed TopicsPediatricsCLLMantle Cell LymphomaTransplant
Many die waiting for `last-chance’ therapyAugust 2, 2022Multiple MyelomaAggressive LymphomasALLCLLCellular TherapyMixed Topics
Drug shortages plague hematology, but preparedness helpsJuly 18, 2022CLLALLHodgkin LymphomaMixed TopicsBusiness of MedicineB Cell LymphomaMantle Cell Lymphoma
Third-generation Black woman physician makes cancer research historyMay 24, 2022Mixed TopicsALLB Cell LymphomaHodgkin LymphomaMantle Cell LymphomaDiversity in MedicineAML
Ex–hospital porter a neglected giant of cancer researchMay 11, 2022ALLAggressive LymphomasB Cell LymphomaCLLDLBCLMantle Cell LymphomaMultiple Myeloma
CLL patients ‘cured’: 10 years post infusion, CAR T cells persistFebruary 3, 2022CLLALLCellular Therapy
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'January 21, 2022TransplantAggressive LymphomasALLDLBCLCLLTranslational ResearchB Cell Lymphoma
